Technical Analysis for UPB - Upstream Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 17.80 | -1.17% | -0.21 |
UPB closed down 1.17 percent on Thursday, November 21, 2024, on approximately normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | N/A | N/A | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Hot IPO Pullback | Bullish Swing Setup | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Below Lower BB | Weakness | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Gapped Down | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Up 10% | about 10 hours ago |
| 60 Minute Opening Range Breakout | about 10 hours ago |
| Rose Above Lower Bollinger Band | about 10 hours ago |
| Up 5% | about 10 hours ago |
| Up 3% | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Inflammatory Diseases Thymic Stromal Lymphopoietin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Immunology Inflammatory Diseases Thymic Stromal Lymphopoietin
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 29.4599 |
| 52 Week Low | 17.0885 |
| Average Volume | 295,199 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 24.70 |
| 10-Day Moving Average | 23.90 |
| Average True Range | 2.06 |
| RSI (14) | 25.93 |
| ADX | 30.64 |
| +DI | 13.44 |
| -DI | 30.63 |
| Chandelier Exit (Long, 3 ATRs) | 23.28 |
| Chandelier Exit (Short, 3 ATRs) | 23.27 |
| Upper Bollinger Bands | 29.74 |
| Lower Bollinger Band | 19.66 |
| Percent B (%b) | -0.18 |
| BandWidth | 40.81 |
| MACD Line | -0.84 |
| MACD Signal Line | 0.11 |
| MACD Histogram | -0.9546 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 22.17 | ||||
| Resistance 3 (R3) | 22.42 | 21.21 | 21.44 | ||
| Resistance 2 (R2) | 21.21 | 20.10 | 21.08 | 21.20 | |
| Resistance 1 (R1) | 19.50 | 19.41 | 20.36 | 19.26 | 20.95 |
| Pivot Point | 18.30 | 18.30 | 18.72 | 18.17 | 18.30 |
| Support 1 (S1) | 16.59 | 17.18 | 17.44 | 16.34 | 14.65 |
| Support 2 (S2) | 15.38 | 16.50 | 15.26 | 14.40 | |
| Support 3 (S3) | 13.68 | 15.38 | 14.16 | ||
| Support 4 (S4) | 13.43 |
